SE9700061D0 - Controlled release composition - Google Patents

Controlled release composition

Info

Publication number
SE9700061D0
SE9700061D0 SE9700061A SE9700061A SE9700061D0 SE 9700061 D0 SE9700061 D0 SE 9700061D0 SE 9700061 A SE9700061 A SE 9700061A SE 9700061 A SE9700061 A SE 9700061A SE 9700061 D0 SE9700061 D0 SE 9700061D0
Authority
SE
Sweden
Prior art keywords
controlled release
composition
release composition
active material
biologically active
Prior art date
Application number
SE9700061A
Other languages
English (en)
Other versions
SE511313C2 (sv
SE9700061L (sv
Inventor
Kaare Larsson
Helena Ljusberg-Wahren
Niels Krog
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Priority to SE9700061A priority Critical patent/SE511313C2/sv
Publication of SE9700061D0 publication Critical patent/SE9700061D0/sv
Priority to EP98900793A priority patent/EP0954287B1/en
Priority to PCT/SE1998/000009 priority patent/WO1998030206A1/en
Priority to AU55832/98A priority patent/AU5583298A/en
Priority to JP53080298A priority patent/JP2001508773A/ja
Priority to CA002277377A priority patent/CA2277377C/en
Priority to US09/341,294 priority patent/US6660278B1/en
Priority to DE69815659T priority patent/DE69815659T2/de
Priority to AT98900793T priority patent/ATE243024T1/de
Publication of SE9700061L publication Critical patent/SE9700061L/sv
Publication of SE511313C2 publication Critical patent/SE511313C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9700061A 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol SE511313C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol
AT98900793T ATE243024T1 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung
JP53080298A JP2001508773A (ja) 1997-01-13 1998-01-08 徐放性組成物
PCT/SE1998/000009 WO1998030206A1 (en) 1997-01-13 1998-01-08 Controlled release composition
AU55832/98A AU5583298A (en) 1997-01-13 1998-01-08 Controlled release composition
EP98900793A EP0954287B1 (en) 1997-01-13 1998-01-08 Controlled release composition
CA002277377A CA2277377C (en) 1997-01-13 1998-01-08 Controlled release composition
US09/341,294 US6660278B1 (en) 1997-01-13 1998-01-08 Controlled release composition
DE69815659T DE69815659T2 (de) 1997-01-13 1998-01-08 Zusammensetzung zur kontrollierten freisetzung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Publications (3)

Publication Number Publication Date
SE9700061D0 true SE9700061D0 (sv) 1997-01-13
SE9700061L SE9700061L (sv) 1998-07-14
SE511313C2 SE511313C2 (sv) 1999-09-06

Family

ID=20405393

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9700061A SE511313C2 (sv) 1997-01-13 1997-01-13 Komposition med reglerad frisättning innefattande fettsyraester av diacylglycerol

Country Status (9)

Country Link
US (1) US6660278B1 (sv)
EP (1) EP0954287B1 (sv)
JP (1) JP2001508773A (sv)
AT (1) ATE243024T1 (sv)
AU (1) AU5583298A (sv)
CA (1) CA2277377C (sv)
DE (1) DE69815659T2 (sv)
SE (1) SE511313C2 (sv)
WO (1) WO1998030206A1 (sv)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020153508A1 (en) 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
CA2463896C (en) * 2001-10-19 2010-05-04 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US7439268B2 (en) * 2003-07-18 2008-10-21 Idexx Laboratories Compositions containing prodrugs of florfenicol and methods of use
US20050049210A1 (en) * 2003-08-27 2005-03-03 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
KR101225257B1 (ko) * 2004-06-04 2013-01-22 카무러스 에이비 유동성 데포 제제
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
WO2006036982A2 (en) 2004-09-28 2006-04-06 Atrium Medical Corporation Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
WO2007047781A2 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
WO2008057344A2 (en) 2006-11-06 2008-05-15 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US7550625B2 (en) * 2007-10-19 2009-06-23 Idexx Laboratories Esters of florfenicol
EP2393472B1 (en) 2008-12-05 2019-06-05 NanoMed Holdings Pty Ltd Amphiphile prodrugs
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
WO2011050388A1 (en) * 2009-10-30 2011-05-05 Monash University Liquid crystal composition and method of use
WO2011145659A1 (ja) * 2010-05-18 2011-11-24 富士フイルム株式会社 カロチノイド含有組成物及びその製造方法
US10322213B2 (en) 2010-07-16 2019-06-18 Atrium Medical Corporation Compositions and methods for altering the rate of hydrolysis of cured oil-based materials
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
RS61377B1 (sr) 2012-07-26 2021-02-26 Camurus Ab Opioidne formulacije
MX2020005442A (es) 2017-11-27 2022-03-30 Umecrine Cognition Ab FORMULACIÓN FARMACÉUTICA DE 3A-ETINIL-3ß-HIDROXIANDROSTAN-17-ONA OXIMA.
WO2019241853A1 (en) 2018-06-21 2019-12-26 NanoMed Holdings Pty Ltd Platinum-based amphiphile prodrugs
JP2024504792A (ja) * 2021-01-29 2024-02-01 イーオーイー オレオ ゲーエムベーハー ポリグリセロール脂肪酸エステル含有組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321393B2 (sv) * 1974-10-19 1978-07-03
US5264460A (en) * 1988-05-30 1993-11-23 Deutsche Solvay-Werke Gmbh Process for preparing nonionic surfactants
GB2222770B (en) 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
IE65045B1 (en) 1990-04-28 1995-10-04 Takeda Chemical Industries Ltd Granulated preparations and method of producing the same
DK0580778T3 (da) * 1991-04-19 2000-01-31 Lds Technologies Inc Konvertible mikroemulsionsformuleringer
SE518578C2 (sv) * 1994-06-15 2002-10-29 Gs Dev Ab Lipidbaserad komposition
US6013269A (en) * 1994-10-12 2000-01-11 The Procter & Gamble Company Cosmetic make-up compositions
SE504582C2 (sv) 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky

Also Published As

Publication number Publication date
EP0954287A1 (en) 1999-11-10
US6660278B1 (en) 2003-12-09
DE69815659D1 (de) 2003-07-24
SE511313C2 (sv) 1999-09-06
WO1998030206A1 (en) 1998-07-16
ATE243024T1 (de) 2003-07-15
JP2001508773A (ja) 2001-07-03
CA2277377C (en) 2007-12-18
SE9700061L (sv) 1998-07-14
AU5583298A (en) 1998-08-03
DE69815659T2 (de) 2004-04-29
EP0954287B1 (en) 2003-06-18
CA2277377A1 (en) 1998-07-16

Similar Documents

Publication Publication Date Title
SE9700061D0 (sv) Controlled release composition
TR199701277T1 (xx) Biyoaktif bile�ikler olarak ya� asidi esterleri.
DE69828635D1 (de) Feste lösungskügelchen
BG93040A (bg) Метод за дрбиване на нефт от нефтени находища
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
CA2225797A1 (en) Active principle carriers containing non-ionic surfactants, and uses thereof, particularly in food, cosmetics and pharmaceuticals
ES2042700T3 (es) Composiciones farmaceuticas con liberacion controlada, y metodo para su preparacion.
MY110984A (en) Immobilized lipases
AU3145995A (en) Indolizine spla2 inhibitors
DK0549774T3 (da) Anvendelse af porøst calciumcarbonat som bærermateriale for in vitro cellekulturer
BR9305636A (pt) Composição compreendendo TCMTB em um portador sólido e métodos para fazer uma composição compreendendo TCMTB e um portador sólido e para impedir o crescimento de um microorganismo.
JPS57117868A (en) Method of combining biological active substance to carrier containing hydroxyl group
ES2103369T3 (es) Derivados de lanolina como sustancias que aceleran la penetracion y su aplicacion en sustancias farmaceuticas u otras formulaciones que contienen sustancias biologicamente activas.
GB2324528A (en) Cytostatic hydroxamic acid derivatives
DE59808546D1 (de) Verwendung von fettsäureniedrigalkylestern in abbeizmitteln
ATE306556T1 (de) Für reduzierende bedingungen empfindliche transfektions-verbindungen, pharmazeutische zusammensezungen die diese enthalten und deren verwendung.
ES2189014T3 (es) Procedimiento para insomerizacion de alcoholes alilicos.
PE97199A1 (es) Composiciones solubilizadas de sertralina
DE69928524D1 (de) Biologisch aktive zusammensetzung
KR970705381A (ko) 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템
ATE267401T1 (de) Technik zur mikroverkapselung von markierungen
ID20810A (id) Metoda merawat luka dangkal tidak dijahit dengan menggunakan komposisi ester siano akrilat terdiri dari bahan anti mikroba
ES2033258T3 (es) Procedimiento para preparar una composicion para sistema terapeuticos transdermales.
UA19786A (uk) Засіб для обробки бульб кортоплі перед посадкою
RO97374B1 (ro) Compozitie de reglare a cresterii plantelor

Legal Events

Date Code Title Description
NUG Patent has lapsed